ELAB logo

ELAB PMGC Holdings Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$1.61
-0.04 (-2.42%)

PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations,…

Market Cap: $1.30Mpmgcholdings.com

Price

No data yet.

Social Signal Score

42
5d
—
30d
43
3 mentions
—
60d
40
4 mentions
—
90d
43
7 mentions
—
news: 7

Revenue

$1.31M+5170.08%
$-1.75M$-729.5K$288.6K$1.31M
Mar 2022Jun 2026

Company Profile

CEO
Graydon Bensler
Sector
Healthcare
Industry
Biotechnology
Employees
33
Beta
-0.27
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-1.95
pmgcholdings.com